| Peer-Reviewed

Delayed Growth and Puberty Revealing Pituitary Stalk Interruption Syndrome Seen at Befelatanana University Hospital in Antananarivo, Madagascar (Case Report)

Received: 4 August 2022     Accepted: 27 August 2022     Published: 5 September 2022
Views:       Downloads:
Abstract

Pituitary stalk interruption syndrome (PSIS) is a rare pathology characterized by a triad associating a thin or absent pituitary stalk, small anterior pituitary gland and ectopic posterior pituitary location on pituitary MRI. It is responsible for global or selective impaired production of anterior pituitary hormones. This case concerns a PSIS discovered in 16 years old boy with delayed growth and puberty, bilateral cryptorchidism treated by orchiopexy and asthenia. His personal history was marked by a breech birth with retention of the after-coming head and neonatal asphyxia. The examination revealed a short stature and the lack of signs of puberty, without associated malformation. Biologically, the plasma IGF-1 level was low at 17.6 ng/ml, the plasma total testosterone level was less than 0.4 nmol/l, the plasma FSH level was low at 0.38 mIU/ml, the plasma LH level was less than 0.12 mIU/ml, plasma cortisol level at 8 am was low at 0.6 µg/dl and the plasma TSH and T4L levels were normal. These abnormalities are in favor of somatotropic, gonadotropic and corticotropic insufficiencies. Posterior pituitary’s function appears intact. Pituitary MRI shows a pituitary stalk interruption syndrome. Androgen and glucocorticoid supplementation was initiated. Recombinant growth hormone is not available. Thus, any delays in growth and/or puberty must be carefully explored and managed early, with a multidisciplinary approach to improve patient’s vital, statural and reproductive prognosis.

Published in International Journal of Diabetes and Endocrinology (Volume 7, Issue 3)
DOI 10.11648/j.ijde.20220703.16
Page(s) 77-80
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Anterior Pituitary Hormones, MRI, Growth, Puberty, Pituitary Stalk Interruption Syndrome (PSIS)

References
[1] Fujisawa I, Kikuchi K, Nishimura K, Togashi K, Itoh K, Noma S, Minami S, Sagoh T, Hiraoka T, Momoi T, Mikawa H, Nakano Y, Itoh H, Konishi J. Interruption of the pituitary stalk: development of an ectopic posterior lobe assessed with MR imaging. Radiology. 1987; 165 (2): 487-9.
[2] El Chehadeh-Djebbar S, Callier P, Masurel-Paulet A, Bensignor C, Méjean N, Payet M, Ragon C, Durand C, Marle N, Mosca-Boidron A, Huet F, Mugneret F, Faivre L, Thauvin-Robinet C. 17q21.31 microdeletion in a patient with pituitary stalk interruption syndrome. Eur J Med Genet. 2011; 54: 369-73.
[3] Ioachimescu AG, Hamrahian AH, Stevens M, Zimmerman RS. The pituitary stalk interruption syndrome: multifaceted presentation in adulthood. Pituitary. 2012; 15: 405-11.
[4] Struthers RS, Vale WW, Arias C, Sawchenko PE, Montminy MR. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature. 1991; 350 (6319): 622-4.
[5] Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970; 45: 13-23.
[6] Styne DM, Grumbach MM. Physiology and disorders of puberty. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams textbook of endocrinology 13 th edition. Philadelphia: Elsevier; 2016. p. 911-1135.
[7] Cooke D W, Divall S A, Radovick S. Normal and Aberrant Growth in Children. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams textbook of endocrinology 13 th edition. Philadelphia: Elsevier; 2016. p. 881-990.
[8] Zhang Q, Zang L, Li YJ, Han BY, Gu WJ, Yan WH, Jin N, Chen K, Du J, Wang XL, Guo QH, Yang GQ, Yang LJ, Ba JM, Lv ZH, Dou JT, Lu JM, Mu YM. Thyrotrophic status in patients with pituitary stalk interruption syndrome. Medicine. 2018; 97: e9084.
[9] Marmouch H, Graja S, Arfa S, Boubaker F, Khochtali I. Late-onset pituitary stalk interruption syndrome (PSIS). Late-onset pituitary stalk interruption syndrome. PAMJl. 2016; 23: 108.
[10] Chen S, Leger J, Garel C. Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. J Clin Endocrinol Metab. 1999; 84 (7): 2408-13.
[11] Kulkarni C, Moorthy S, Pullara SK, Rajeshkannan R, Unnikrishnanet AG. Pituitary stalk interruption syndrome: Comparison of clinico-radiological features in adults and children with review of literature. Indian J Radiol Imaging. 2012; 22 (3): 182-5.
[12] Patkar D, Patankar T, Krishnan A, Prasad S, Shah J, Limdi J. MR imaging in children with ectopic pituitary gland and anterior hypopituitarism. J Postgrad Med. 1999; 45 (3): 81-3.
[13] Wang CZ, Guo LL, Han BY, Su X, Guo QH, Mu YM. Pituitary Stalk Interruption Syndrome: From Clinical Findings to Pathogenesis. J Neuroendocrinol. 2017; 29 (1). doi: 10.1111/jne.12451.
[14] Liu Z, Chen X. A novel missense mutation in human Receptor Roundabout-1 (ROBO1) gene associated with pituitary stalk interruption syndrome. J Clin Res Pediatr Endocrinol. 2020; 12 (2): 212-7.
[15] Karaca E, Buyukkaya R, Pehlivan D, Charng WL, Yaykasli KO, Bayram Y, Gambin T, Withers M, Atik MM, Arslanoglu I, Bolu S, Erdin S, Buyukkaya A, Yaykasli E, Zhangiani SN, Muzny DM, Gibbs RA, Lupski JR. Whole-exome sequencing identifies homozygous GPR161 mutation in a family with pituitary stalk interruption syndrome. J Clin Endocrinol Metab. 2015; 100 (1): E140-7.
[16] Gosi SK, Kanduri S, Garla VV. Pituitary stalk interruption syndrome. BMJ Case Rep. 2019; 12 (4): e230133.
[17] Maghnie M, Larizza D, Triulzi F, Sampaolo P, Scotti G, Severi F. Hypopituitarism and stalk agenesis: a congenital syndrome worsened by breech delivery? Horm Res. 1991; 35 (3-4): 104-8.
[18] Mo D, Blum WF, Rosilio M, Webb SM, Qi R, Strasburger CJ. Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study. J Clin Endocrinol Metab. 2014; 99 (12): 4581-8.
[19] Kao KT, Stargatt R, Zacharin M. Adult quality of life and psychosocial outcomes of childhood onset hypopituitarism. Horm Res Paediatr. 2015; 84: 94-101.
[20] Bouvattier C, Maione L, Bouligand J, Dodé C, Guiochon-Mantel A, Young J. Neonatal gonadotropin therapy in male congenital hypogonadism. Nat Rev Endocrinol. 2011; 8 (3): 172-82.
[21] Fernandez-Rodriguez E, Quinteiro C, Barreiro J, Marazuela M, Pereiro I, Peino R, Cabezas-Agricola JM, Dominguez F, Casanueva FF, Bernabeu I. Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis. Neuroendocrinology. 2011; 93 (3): 181-8.
[22] Ndour O, Fall M, Faye Fall AL, Diouf C, Ndoye NA, Ngom G, Ndoye M. Epidemiological, clinical and therapeutic aspects of cryptorchidism in children: analysis of 123 cases. Afr J Urol. 2015; 21 (1): 10-4.
Cite This Article
  • APA Style

    Rija Eric Raherison, Thierry Razanamparany, Sitraka Angelo Raharinavalona, Miora Maeva Arielle Andrianiaina, Radonirina Lazasoa Andrianasolo, et al. (2022). Delayed Growth and Puberty Revealing Pituitary Stalk Interruption Syndrome Seen at Befelatanana University Hospital in Antananarivo, Madagascar (Case Report). International Journal of Diabetes and Endocrinology, 7(3), 77-80. https://doi.org/10.11648/j.ijde.20220703.16

    Copy | Download

    ACS Style

    Rija Eric Raherison; Thierry Razanamparany; Sitraka Angelo Raharinavalona; Miora Maeva Arielle Andrianiaina; Radonirina Lazasoa Andrianasolo, et al. Delayed Growth and Puberty Revealing Pituitary Stalk Interruption Syndrome Seen at Befelatanana University Hospital in Antananarivo, Madagascar (Case Report). Int. J. Diabetes Endocrinol. 2022, 7(3), 77-80. doi: 10.11648/j.ijde.20220703.16

    Copy | Download

    AMA Style

    Rija Eric Raherison, Thierry Razanamparany, Sitraka Angelo Raharinavalona, Miora Maeva Arielle Andrianiaina, Radonirina Lazasoa Andrianasolo, et al. Delayed Growth and Puberty Revealing Pituitary Stalk Interruption Syndrome Seen at Befelatanana University Hospital in Antananarivo, Madagascar (Case Report). Int J Diabetes Endocrinol. 2022;7(3):77-80. doi: 10.11648/j.ijde.20220703.16

    Copy | Download

  • @article{10.11648/j.ijde.20220703.16,
      author = {Rija Eric Raherison and Thierry Razanamparany and Sitraka Angelo Raharinavalona and Miora Maeva Arielle Andrianiaina and Radonirina Lazasoa Andrianasolo and Andrianirina Dave Patrick Rakotomalala},
      title = {Delayed Growth and Puberty Revealing Pituitary Stalk Interruption Syndrome Seen at Befelatanana University Hospital in Antananarivo, Madagascar (Case Report)},
      journal = {International Journal of Diabetes and Endocrinology},
      volume = {7},
      number = {3},
      pages = {77-80},
      doi = {10.11648/j.ijde.20220703.16},
      url = {https://doi.org/10.11648/j.ijde.20220703.16},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20220703.16},
      abstract = {Pituitary stalk interruption syndrome (PSIS) is a rare pathology characterized by a triad associating a thin or absent pituitary stalk, small anterior pituitary gland and ectopic posterior pituitary location on pituitary MRI. It is responsible for global or selective impaired production of anterior pituitary hormones. This case concerns a PSIS discovered in 16 years old boy with delayed growth and puberty, bilateral cryptorchidism treated by orchiopexy and asthenia. His personal history was marked by a breech birth with retention of the after-coming head and neonatal asphyxia. The examination revealed a short stature and the lack of signs of puberty, without associated malformation. Biologically, the plasma IGF-1 level was low at 17.6 ng/ml, the plasma total testosterone level was less than 0.4 nmol/l, the plasma FSH level was low at 0.38 mIU/ml, the plasma LH level was less than 0.12 mIU/ml, plasma cortisol level at 8 am was low at 0.6 µg/dl and the plasma TSH and T4L levels were normal. These abnormalities are in favor of somatotropic, gonadotropic and corticotropic insufficiencies. Posterior pituitary’s function appears intact. Pituitary MRI shows a pituitary stalk interruption syndrome. Androgen and glucocorticoid supplementation was initiated. Recombinant growth hormone is not available. Thus, any delays in growth and/or puberty must be carefully explored and managed early, with a multidisciplinary approach to improve patient’s vital, statural and reproductive prognosis.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Delayed Growth and Puberty Revealing Pituitary Stalk Interruption Syndrome Seen at Befelatanana University Hospital in Antananarivo, Madagascar (Case Report)
    AU  - Rija Eric Raherison
    AU  - Thierry Razanamparany
    AU  - Sitraka Angelo Raharinavalona
    AU  - Miora Maeva Arielle Andrianiaina
    AU  - Radonirina Lazasoa Andrianasolo
    AU  - Andrianirina Dave Patrick Rakotomalala
    Y1  - 2022/09/05
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ijde.20220703.16
    DO  - 10.11648/j.ijde.20220703.16
    T2  - International Journal of Diabetes and Endocrinology
    JF  - International Journal of Diabetes and Endocrinology
    JO  - International Journal of Diabetes and Endocrinology
    SP  - 77
    EP  - 80
    PB  - Science Publishing Group
    SN  - 2640-1371
    UR  - https://doi.org/10.11648/j.ijde.20220703.16
    AB  - Pituitary stalk interruption syndrome (PSIS) is a rare pathology characterized by a triad associating a thin or absent pituitary stalk, small anterior pituitary gland and ectopic posterior pituitary location on pituitary MRI. It is responsible for global or selective impaired production of anterior pituitary hormones. This case concerns a PSIS discovered in 16 years old boy with delayed growth and puberty, bilateral cryptorchidism treated by orchiopexy and asthenia. His personal history was marked by a breech birth with retention of the after-coming head and neonatal asphyxia. The examination revealed a short stature and the lack of signs of puberty, without associated malformation. Biologically, the plasma IGF-1 level was low at 17.6 ng/ml, the plasma total testosterone level was less than 0.4 nmol/l, the plasma FSH level was low at 0.38 mIU/ml, the plasma LH level was less than 0.12 mIU/ml, plasma cortisol level at 8 am was low at 0.6 µg/dl and the plasma TSH and T4L levels were normal. These abnormalities are in favor of somatotropic, gonadotropic and corticotropic insufficiencies. Posterior pituitary’s function appears intact. Pituitary MRI shows a pituitary stalk interruption syndrome. Androgen and glucocorticoid supplementation was initiated. Recombinant growth hormone is not available. Thus, any delays in growth and/or puberty must be carefully explored and managed early, with a multidisciplinary approach to improve patient’s vital, statural and reproductive prognosis.
    VL  - 7
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar

  • Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar

  • Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar

  • Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar

  • Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar

  • Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar

  • Sections